Study shows not all adrenal carcinoma patients need mitotane after surgery

After the complete tumor resection, not all patients with an adrenocortical carcinoma require the previous standard therapy Mitotane. Professors Martin Fassnacht and Massimo Terzolo show this in a clinical trial.

Understanding ICH Guideline Q14 – Pharmaceutical Technology

Q14 is a new guideline detailing the elements of minimal and enhanced approaches for analytical procedure development. While the traditional minimal development approach remains valid,

August 1, 2024

Abeona Therapeutics raises funds to launch cell therapy

EB-101 is being developed for recessive dystrophic epidermolysis bullosa. Credit: CDC on Unsplash. Clinical-stage biopharmaceutical firm Abeona Therapeutics has raised $25m from its current select investors to

July 4, 2023

Layoffs at Ginkgo and Xellia; Melodia and Alivexis ink $275M partnership

Plus, news about Rapafusyn Pharmaceuticals: Ginkgo Bioworks lays off 158 employees: The cuts come after the Boston, MA-based biotech said last month … Sign up

June 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.